|
1
|
Lee DM and Weinblatt ME: Rheumatoid
arthritis. Lancet. 358:903–911. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gheorghe KR, Sadique S, Leclerc P, et al:
Limited effect of anti-rheumatic treatment on15-prostaglandin
dehydrogenase in rheumatoid arthritis synovial tissue. Arthritis
Res Ther. 14:R1212012. View
Article : Google Scholar
|
|
3
|
Westman M, Korotkova M, afKlint E, et al:
Expression of microsomal prostaglandin Esynthase 1 in rheumatoid
arthritis synovium. Arthritis Rheum. 50:1774–1780. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tai HH: Prostaglandin catabolic enzymes as
tumor suppressors. Cancer Metastasis Rev. 30:409–417. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gosset M, Berenbaum F, Levy A, Pigenet A,
Thirion S, Cavadias S and Jacques C: Mechanical stress and
prosta-glandin E2 synthesis in cartilage. Biorheology. 45:301–320.
2008.
|
|
6
|
Lousse JC, Defrère S, Colette S, Van
Langendonckt A and Donnez J: Expressionof eicosanoid biosynthetic
and catabolic enzymes in peritoneal endometriosis. Hum Reprod.
25:734–741. 2010. View Article : Google Scholar
|
|
7
|
Celis JE, Ostergaard M, Basse B, et al:
Loss of adipocyte-type fatty acid binding protein and other protein
biomarkers is associated with progression of human bladder
transitional cell carcinomas. Cancer Res. 56:4782–4790.
1996.PubMed/NCBI
|
|
8
|
Gee JR, Montoya RG, Khaled HM, Sabichi AL
and Grossman HB: Cytokeratin 20, AN43, PGDH and COX-2 expression in
transitional and squamous cell carcinoma of the bladder. Urol
Oncol. 21:266–270. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tseng-Rogenski S, Gee J, Ignatoski KW, et
al: Loss of 15-hydroxyprostaglandin dehydrogenase expression
contributes to bladder cancer progression. Am J Pathol.
176:1462–1468. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yan M, Rerko RM, Platzer P, et al:
15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogeneantagonist,
is a TGF-beta-induced suppressor of human gastrointestinal cancers.
Proc Natl Acad Sci USA. 101:17468–17473. 2004. View Article : Google Scholar
|
|
11
|
Gosset M, Berenbaum F, Salvat C, et al:
Crucial role of visfatin/pre-B cell colony-enhancing factor in
matrix degradation and prostaglandin E2 synthesis in chondrocytes:
Possible influence on osteoarthritis. Arthritis Rheum.
58:1399–1409. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Smolen JS, van der Heijde D, Machold KP,
Aletaha D and Landewé R: Proposal for a new nomenclature of
disease-modifying antirheumatic drugs. Ann Rheum Dis. 73:3–5. 2014.
View Article : Google Scholar
|
|
13
|
Mercer E, Rekedal L, Garg R, Lu B,
Massarotti EM and Solomon DH: Hydroxychloroquine improves insulin
sensitivity in obese non-diabeticindividuals. Arthritis Res Ther.
14:R1352012. View
Article : Google Scholar
|
|
14
|
Unübol M, Ayhan M and Guney E:
Hypoglycemia induced by hydroxychloroquine in a patient treated for
rheumatoid arthritis. J Clin Rheumatol. 17:46–47. 2011. View Article : Google Scholar
|
|
15
|
Nah SS, Won HJ, Park HJ, et al: Melatonin
inhibits human fibroblast-like synoviocyte proliferation via extra
cell ular signal-regulated protein kinase/P21(CIP1)/P27(KIP1)
pathways. J Pineal Res. 47:70–74. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Clive R, Shi SR, Chen C, et al:
Comparative study of antigen retrieval heating methods: Microwave,
microwave and pressure cooker, autoclave, and steamer. Biotechnic
& Histochemistry. 5:263–270. 1996.
|
|
17
|
Kim HJ, Eom CY, Kwon J, et al: Roles of
interferon-gamma and its target genes in schizophrenia:
Proteomics-based reverse genetics from mouse to human. Proteomics.
12:1815–1829. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tai HH, Ensor CM, Tong M, Zhou H and Yan
F: Prostaglandin catabolizing enzymes. Prostaglandins Other Lipid
Mediat. 68–69:483–493. 2002. View Article : Google Scholar
|
|
19
|
Tai HH, Cho H, Tong M and Ding Y:
NAD+-linked 15-hydroxy-prostaglandindehydrogenase: structure and
biological functions. Curr Pharm Des. 12:955–962. 2006. View Article : Google Scholar
|
|
20
|
Otani T, Yamaguchi K, Scherl E, et al:
Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase
are reduced in inflammatory bowel disease: evidence for involvement
of TNF-alpha. Am J Physiol Gastrointest Liver Physiol.
290:G361–G368. 2006. View Article : Google Scholar
|
|
21
|
Lou LH, Jing DD, Lai YX, Lu YY, Li JK and
Wu K: 15-PGDH is reduced and induces apoptosis and cell cycle
arrest in gastric carcinoma. World J Gastroenterol. 18:1028–1037.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tong M and Tai HH: 15-Hydroxyprostaglandin
dehydrogenase can be induced by dexamethasone and other
glucocorticoids at the therapeutic level inA549 human lung
adenocarcinoma cells. Arch Biochem Biophys. 435:50–55. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chi X, Freeman BM, Tong M, Zhao Y and Tai
HH: 15-Hydroxyprostaglandindehydrogenase (15-PGDH) is up-regulated
by flurbiprofen and other non-steroidal anti-inflammatory drugs in
human colon cancer HT29 cells. Arch Biochem Biophys. 487:139–145.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thwaites C and Finney A: Rheumatoid
arthritis. 2: Exploring treatment options to achieve early control
and remission. Nurs Times. 106:18–20. 2010.PubMed/NCBI
|
|
25
|
Min JK, Lee HJ, Lee WS, et al: Effects of
hydroxychloroquine on the metabolism of fas ligand of T cells. J
Korean Rheum Assoc. 7:127–139. 2000.
|
|
26
|
Mackenzie AH: Pharmacologic actions of
4-aminoquinoline compounds. Am J Med. 75:5–10. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dubois EL: Antimalarials in the management
of discoid and systemic lupus erythematosus. Semin Arthritis Rheum.
8:33–51. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ben-Chetrit E, Fischel R, Hinz B and Levy
M: The effects of colchicine and hydroxychloroquine on the
cyclo-oxygenases COX-1 and COX-2. Rheumatol Int. 25:332–335. 2005.
View Article : Google Scholar
|
|
29
|
Cho W, Kim Y, Jeoung DI, Kim YM and Choe
J: IL-4 and IL-13 suppress prostaglandins production in human
follicular dendritic cells by repressingCOX-2 and mPGES-1
expression through JAK1 and STAT6. Mol Immunol. 48:966–972. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nagano S, Otsuka T, Niiro H, et al:
Molecular mechanisms of lipopolysaccharide-induced cyclooxygenase-2
expression inhuman neutrophils: involvement of the
mitogen-activated protein kinasepathway and regulation by
anti-inflammatory cytokines. Int Immunol. 14:733–740. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Singer II, Kawka DW, Schloemann S, Tessner
T, Riehl T and Stenson WF: Cyclooxygenase 2 is induced in colonic
epithelial cells in inflammatory bowel disease. Gastroenterology.
115:297–306. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Subbaramaiah K, Yoshimatsu K, Scherl E, et
al: Microsomal prostaglandin E synthase-1 is overexpressed in
inflammatory bowel disease. Evidence for involvement of the
transcription factor Egr-1. J Biol Chem. 279:12647–12658. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chi X and Tai HH: Interleukin-4
up-regulates 15-hydroxypros-taglandindehydrogenase (15-PGDH) in
human lung cancer cells. Exp Cell Res. 316:2251–2259. 2010.
View Article : Google Scholar : PubMed/NCBI
|
